Gamma Medica-Ideas Inc.
Digital molecular imaging systems developer Gamma Medica-Ideas Inc. of Northridge, Calif., has signed an exclusive licensing and commercialization agreement with the Mayo Clinic to further develop and commercialize a suite of technologies invented by a team of Mayo physicians and scientists. The company will use the licensed technology in conjunction with its Lumagem molecular breast imaging system to improve cancer diagnosis in women with dense breasts.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024